In 1993, a system of effectively extending the patent term of protection for particular pharmaceutical products was introduced by the use of supplementary protection certificates (“SPCs”), further to Council Regulation (EEC) No 1768/92 (now Regulation 469/2009/EC) (“SPC Regulation”).

This Guidance Note explains the purpose of SPCs, the conditions for obtaining them and how the length of protection is determined.

This content is restricted to members. To view this content please register or login below to view this content.

Register to receive up-to-date information and advice on tax developments within your industry.